Literature DB >> 9819793

Initial transforming event in myelodysplastic syndromes may be viral: case for cytomegalovirus.

A Raza1.   

Abstract

Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders which begin in a pluripotential bone marrow (BM) stem cell. This early stem cell is believed to acquire a growth advantage over its neighbors as a result of an initial transforming event, the nature of which has remained obscure. In this paper, we propose that pathogens such as those belonging to the herpesvirus family of DNA viruses may play a role in the initial transformation of the stem cell. The case for cytomegalovirus (CMV) as a representative of this family of viruses is discussed at length and a molecular mechanism which may be involved in the oncogenic activity of CMV is proposed. No proof has been presented to implicate CMV directly in MDS, but circumstantial evidence which supports such a possibility is provided.

Entities:  

Mesh:

Year:  1998        PMID: 9819793     DOI: 10.1007/BF02821935

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  71 in total

1.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

Authors:  K Helin; J A Lees; M Vidal; N Dyson; E Harlow; A Fattaey
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

2.  Letter: Cytomegalovirus-induced thrombocytopenia and hemolysis in an adult.

Authors:  A I Harris; R J Meyer; E A Brody
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

Review 3.  Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult.

Authors:  M J Eisenberg; B Kaplan
Journal:  West J Med       Date:  1993-05

4.  Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation.

Authors:  P J Fialkow; J W Singer; J W Adamson; R L Berkow; J M Friedman; R J Jacobson; J W Moohr
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

5.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

6.  Cytomegalovirus-associated myelodysplasia and thrombocytopenia in an immunocompetent adult.

Authors:  M Miyahara; Y Shimamoto; H Yamada; K Shibata; M Matsuzaki; K Ono
Journal:  Ann Hematol       Date:  1997-02       Impact factor: 3.673

7.  Replication of human cytomegalovirus in human peripheral blood T cells.

Authors:  R W Braun; H C Reiser
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

8.  Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.

Authors:  J W Janssen; M Buschle; M Layton; H G Drexler; J Lyons; H van den Berghe; H Heimpel; B Kubanek; E Kleihauer; G J Mufti
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

9.  Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes.

Authors:  S D Mundle; P Venugopal; J D Cartlidge; D V Pandav; L Broady-Robinson; S Gezer; E L Robin; S R Rifkin; M Klein; D E Alston; B M Hernandez; D Rosi; S Alvi; V T Shetty; S A Gregory; A Raza
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

10.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors.

Authors:  M Mendelson; S Monard; P Sissons; J Sinclair
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

View more
  1 in total

1.  Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?

Authors:  Ivana Juric; Lea Katalinic; Vesna Furic-Cunko; Nikolina Basic-Jukic
Journal:  Int Urol Nephrol       Date:  2021-11-23       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.